EOLS Stock Discussion
Evolus, Inc. Description
Evolus Inc is engaged in providing physicians and their patients with expanded choices in medical aesthetic treatments and procedures. Its product candidate is an injectable formulation of a 900 kDa Botulinum toxin Type A complex.
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Medicine Clinical Medicine Toxins Plastic Surgery Botulinum Toxin Botulism Aesthetic Medicine Neurotoxins
Recent Comments
- TraderMike on Bollinger Band Squeeze
- TraderMike on Bollinger Band Squeeze
- OpenCat584 on Bollinger Band Squeeze
- Dr_Duru on Expansion Breakout
- TraderMike on New Scans: Strong, Oversold Stocks and Weak, Overbought Stocks
From the Blog
Featured Articles